Data on 2D culture characterisation of potential markers in human HER2-positive breast cancer cell lines
Son H. Pham,
Lyn R. Griffiths,
Rachel K. Okolicsanyi,
Larisa M. Haupt
Affiliations
Son H. Pham
Stem Cell and Neurogenesis Group, Centre for Genomics and Personalised Health, Genomics Research Centre, School of Biomedical Sciences, Queensland University of Technology (QUT), 60 Musk Ave., Kelvin Grove, Queensland 4059, Australia
Lyn R. Griffiths
Stem Cell and Neurogenesis Group, Centre for Genomics and Personalised Health, Genomics Research Centre, School of Biomedical Sciences, Queensland University of Technology (QUT), 60 Musk Ave., Kelvin Grove, Queensland 4059, Australia
Rachel K. Okolicsanyi
Stem Cell and Neurogenesis Group, Centre for Genomics and Personalised Health, Genomics Research Centre, School of Biomedical Sciences, Queensland University of Technology (QUT), 60 Musk Ave., Kelvin Grove, Queensland 4059, Australia
Larisa M. Haupt
Stem Cell and Neurogenesis Group, Centre for Genomics and Personalised Health, Genomics Research Centre, School of Biomedical Sciences, Queensland University of Technology (QUT), 60 Musk Ave., Kelvin Grove, Queensland 4059, Australia; ARC Training Centre for Cell and Tissue Engineering Technologies, Queensland University of Technology (QUT), Australia; Corresponding author at: Genomics Research Centre, Queensland University of Technology, 60 Musk Avenue, Kelvin Grove, Queensland 4059, Australia.
To obtain this dataset, two human HER2-positive breast cancer cell lines (SKBR3 and MDA-MB-453 cell lines) were cultured in basal growth media to 80% confluence. Cells were passaged and total RNA extracted, RNA converted to cDNA and diluted to a working concentration of 40 ng/µL. Gene expression panels of cancer markers including Fibroblast growth factors (FGF), FGF receptors (FGFRs), cyclin-dependent kinases, cytokeratins, and WNT pathway components were then examined using Q-PCR. Gene expression was normalised against the expression of the endogenous gene 18S. This article describes the data used in the research article “Syndecan-4 regulates the HER2-positive breast cancer cell proliferation cells via CK19/AKT signaling” [1]. The data presented demonstrates the range of gene expression profiles of these cells and aims to provide more detail of all gene expression changes observed in these cell lines.
